The Globe and Mail reports in its Thursday, Nov. 7, edition that RBC analyst Drew McReynolds continues to rate Thomson Reuters "sector perform." The Globe's David Leeder writes in the Eye On Equities column that Mr. McReynolds hiked his share target to $173 (U.S.) from $171 (U.S.). Analysts on average target the shares at $170.33 (U.S.). Mr. McReynolds says in a note: "At current valuation, we believe the bar to deliver consolidated organic revenue growth in excess of 6 per cent has risen with the organic revenue growth trajectory over the 2025 26 period now taking centre stage. While we remain patient for more timely and/or attractive accumulation points, we believe the current valuation level is fundamentally justified provided that: (I) management meets or exceeds a 7 to 8-per-cent organic revenue growth trajectory by 2026 without meaningful changes to the company's current margin, capex and FCF conversion profile; and (ii) solid execution on the GenAI playbook continues with little change to the current GenAI narrative including perceived opportunities and risks. ... We believe the stage [is set] for 7 to 8-per-cent consolidated growth in 2025E and 2026E. Thomson Reuters continues to meet rising expectations."